SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs >

Amarantus Bioscience Holdings Inc. (AMBS)

AMBS RSS Feed
Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: JPetroInc, zoomboom
Search This Board: 
Last Post: 12/15/2017 3:38:31 PM - Followers: 677 - Board type: Free - Posts Today: 17

 

(AMBS) Amarantus BioScience Holdings, Inc. 

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis.
The company has licensed Eltoprazine, a Phase 3 ready Parkinsons Levadopa induced Dyskinesia.

 (MANF) is a human growth factor that plays a key role in the prevention of apoptosis (cell death). It is being developed for the potential treatment of RP, Parkinson's disease, Wolfram syndrome, diabetes, Alzheimer's disease and traumatic brain injury.

ESS, previously known as PermaDerm®  is being developed to be the only tissue-engineered skin prepared from autologous (patient's own) skin cells consisting of both epidermal and dermal layers. A small harvested section of the patient's own skin can be grown to graft an area one hundred times its size in as little as thirty days. 
For further information, please visit www.Amarantus.com, or connect with the company in FacebookTwitter, LinkedIn & Google+
 
                                                                                       


 

NEWS



Bio-engineering skin to treat severe burns
 
 

   Videos

 

Gerald Commissiong, CEO of Amarantus BioScience Holdings, Inc. (OTCQX: AMBS) chats with Bob Power, OTC Markets VP of Corporate Services
Mar. 18, 2016

 
SNNLive with Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS)  
December 2015


 

ESS Patients: Dr. Ahrenholz Interview Part 1 
 

ESS vs the Competition: Dr. Ahrenholz Interview Part 2

The Need for ESS: Dr. Ahrenholz Interview Part 3
 
 
 

 
                                                                                                                
 
 
    
       
 


                                                               Contact Information

Amarantus BioScience Holdings, Inc.
655 Montgomery Street
Suite 900
San Francisco, CA 94111

 

c/o ICS Corporate Services SA
29 quai du Mont Blanc
CH-1201 Geneva
Switzerland












 

info@amarantus.com
pr@amarantus.com


Phone: (415) 688-4484
Fax: (408) 852-4427


Gerald's email address
Gerald@amarantus.com



IR Calendar 






 

INVESTOR RELATIONS

Jenene Thomas Communications
Jenene Thomas
T: 908-938-1475

ir@amarantus.com


 

TRANSFER AGENT

VStock Transfer, LLC
Allison Niccols
77 Spruce Street
Suite 201
Cedarhurst, N 11516
T: 212-828-8436
F: 646-536-3179
info@vstocktransfer.com
www.VStockTransfer.com

 

 
 
                                                                            

 

SureTrader
Interactive Brokers Advertisement
AMBS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS News: Amarantus Subsidiary MANF Therapeutics Announces Publication in Science Magazine of Positive Animal Data for MANF in Treatment 12/14/2017 08:00:00 AM
AMBS News: Amarantus Subsidiary MANF Therapeutics Receives Notice of Allowance from U.S. Patent & Trademark Office Covering MANF Treatment 12/11/2017 08:00:00 AM
AMBS News: Amarantus Subsidiary Elto Pharma Announces the Issuance of Patents in Singapore and New Zealand Parkinson's LID 12/08/2017 09:42:20 AM
AMBS News: Amarantus Subsidiary Elto Pharma Receives Notice of Allowance for European Patent Application Covering Method of Treating... 12/05/2017 07:45:00 AM
AMBS News: Termination of Registration of a Class of Security Under Section 12(g) (15-12g) 12/04/2017 04:29:48 PM
PostSubject
#126739   Wow .I should have listened to myself Jumpinjackas 12/15/17 03:38:31 PM
#126738   I've owned shares for a long time (and cybermich 12/15/17 03:13:56 PM
#126737   Closing in on 5M in Volume and breaking zoomboom 12/15/17 02:30:55 PM
#126736   New 52 Week High. $AMBS again zoomboom 12/15/17 01:43:46 PM
#126735   Every time i Post new 52 week High zoomboom 12/15/17 01:32:57 PM
#126734   only need $2 - $3 pps for uplisting JPetroInc 12/15/17 01:30:26 PM
#126733   Impressive Volume New 52 zoomboom 12/15/17 01:28:00 PM
#126732   its more than likely the $1.5-Mil. is already JPetroInc 12/15/17 01:13:12 PM
#126729   Looks like Trying for new highs again $AMBS Something is up zoomboom 12/15/17 11:41:04 AM
#126727   New 52 week High $AMBS. And Thanks zoomboom 12/15/17 11:11:46 AM
#126726   Unless some miracle happens where the conman CEO SidVicious 12/15/17 10:47:58 AM
#126725   Beware the upcoming, inevitable crash.p 7Bullet7 12/15/17 10:41:32 AM
#126724   New 52 week High. $AMBS Nice Volume Again zoomboom 12/15/17 09:57:11 AM
#126721   Another 1 share for 150 share split will a surfer 12/14/17 06:53:02 PM
#126720   sure thing - just know the fault lies JPetroInc 12/14/17 06:37:16 PM
#126719   No need to be sorry. He knew all zoomboom 12/14/17 03:31:32 PM
#126718   Thanks JP, for that perspective, IP is Tadasana 12/14/17 03:14:44 PM
#126717   here since Nov., 2012 JPetroInc 12/14/17 02:53:19 PM
#126716   JPetroInc, if Gerald is such a loser, liar, Tadasana 12/14/17 01:58:43 PM
#126715   peeps don't even know this guy JPetroInc 12/14/17 01:35:38 PM
#126714   Nice Volume again. $AMBS zoomboom 12/14/17 01:27:11 PM
#126713   Just Name Dropping as if they know something zoomboom 12/14/17 01:26:07 PM
#126712   JP , who is Spence? leslunier 12/14/17 01:16:48 PM
#126710   all for the euphoric rise guys JPetroInc 12/14/17 12:39:20 PM
#126708   jugs, Fair enough, what an altruistic guy!, why Tadasana 12/14/17 12:09:25 PM
#126705   Who says i lost? , I zoomboom 12/14/17 11:09:19 AM
#126704   That's great. Did you make up for all SidVicious 12/14/17 10:56:03 AM
#126703   These PR's cost money and lots of it JPetroInc 12/14/17 09:58:37 AM
#126702   Nice 200% plus gain in the last bunch zoomboom 12/14/17 09:45:05 AM
#126701   Ive been out of for a few years a surfer 12/14/17 09:26:42 AM
#126700   All of this is great but unfortunately does SidVicious 12/14/17 09:16:57 AM
#126699   Thanks for the post. $AMBS zoomboom 12/14/17 08:45:57 AM
#126698   Amarantus Subsidiary MANF Therapeutics Announces Publication in Science a surfer 12/14/17 08:30:55 AM
#126697   I am an AMBS stockholder in case you JPetroInc 12/13/17 04:13:05 PM
#126695   Nice Volume $AMBS zoomboom 12/13/17 03:38:06 PM
#126692   was never in jail JPetroInc 12/13/17 08:31:47 AM
#126691   Not the reason. But zoomboom 12/12/17 11:56:05 PM
#126690   lGerald will no longer be speaking on the JPetroInc 12/12/17 08:59:40 PM
#126689   Sid it has been my personal dealings with JPetroInc 12/12/17 08:34:43 PM
#126688   Amarantus Subsidiary MANF Therapeutics Receives Notice of Allowance zoomboom 12/11/17 08:49:02 AM
#126687   ”Treatment of Motor Symptoms and Movement Disorder Side 7charity 12/09/17 05:11:03 PM
#126683   Obviously, facts surrounding the history of this company SidVicious 12/09/17 10:10:20 AM
#126681   Actually it doesn't. All it does is protect SidVicious 12/09/17 09:16:05 AM
#126680   It makes Eltoprazine a more valuable asset. zoomboom 12/08/17 12:11:35 PM
#126679   The patents in Singapore and New Zealand are 7Bullet7 12/08/17 11:57:05 AM
#126677   What ever happened to the grant funding available leslunier 12/08/17 11:07:32 AM
#126676   $AMBS baby, choo chooo jjr04001 12/08/17 10:26:06 AM
#126675   Amarantus Subsidiary Elto Pharma Announces the Issuance of zoomboom 12/08/17 10:16:47 AM
#126674   Yes. Hence the silence around zoomboom 12/08/17 10:11:58 AM
#126673   $AMBS let's finally get this party started jjr04001 12/07/17 03:51:26 PM
PostSubject